2020
DOI: 10.1093/ofid/ofaa439.371
|View full text |Cite
|
Sign up to set email alerts
|

61. Using Machine Learning for Prediction of Poor Clinical Outcomes in Adult Patients Hospitalized with COVID-19

Abstract: Background As the ongoing COVID-19 pandemic develops, there is a need for prediction rules to guide clinical decisions. Previous reports have identified risk factors using statistical inference model. The primary goal of these models is to characterize the relationship between variables and outcomes, not to make predictions. In contrast, the primary purpose of machine learning is obtaining a model that can make repeatable predictions. The objective of this study is to develop decision rules t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(9 citation statements)
references
References 0 publications
0
9
0
Order By: Relevance
“…20 This review of the safety profile of M-M-RII from 2010 to 2019 confirms the results of earlier clinical trials as well as 2 reviews of safety data, each assessing ≥30 years of postmarketing experience with M-M-RII. 30,31 Several studies assessed the performance of M-M-RII when administered with other routinely recommended vaccines. Concomitant administration of multiple vaccines was well tolerated and did not impair the immunogenicity of M-M-RII or the other vaccines studied.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…20 This review of the safety profile of M-M-RII from 2010 to 2019 confirms the results of earlier clinical trials as well as 2 reviews of safety data, each assessing ≥30 years of postmarketing experience with M-M-RII. 30,31 Several studies assessed the performance of M-M-RII when administered with other routinely recommended vaccines. Concomitant administration of multiple vaccines was well tolerated and did not impair the immunogenicity of M-M-RII or the other vaccines studied.…”
Section: Discussionmentioning
confidence: 99%
“…20 This review of the safety profile of M-M-RII from 2010 to 2019 confirms the results of earlier clinical trials as well as 2 reviews of safety data, each assessing ≥30 years of postmarketing experience with M-M-RII. 30,31…”
Section: Discussionmentioning
confidence: 99%
“…Rodriguez-Nava et al used a random forest algorithm that predicted ICU admissions with an AUC of 0.82 and mortality with an AUC of 0.70 ( 10 ). Similarly, Jimenez-Solemm et al used a random forest machine learning model using a Danish dataset with 3,944 COVID-19 patients that predicted ICU admissions with an AUC of 0.820, mortality with an AUC of 0.902, hospital admission with an AUC of 0.820 and ventilator treatment with an AUC of 0.815 ( 11 ).…”
Section: Related Workmentioning
confidence: 99%
“…Measles causes a lengthy and unpleasant acute illness and can result in serious long-term illness in children and adults [ 3 ]. Until the 1990s, the hope of eliminating measles seemed possible following the successful development of effective vaccines, given individually or in the combined measles, mumps, and rubella (MMR) vaccine [ 4 6 ]. However, from the 1990s, false claims that the MMR vaccine was associated with childhood autism resulted in vaccine hesitancy, including in developed countries [ 4 6 ].…”
Section: Introductionmentioning
confidence: 99%